Publisher
Springer Science and Business Media LLC
Subject
Hematology,Histology,Pathology and Forensic Medicine
Reference27 articles.
1. Swerdlow SH, Berger F, Pileri SA, Harris NL, Jaffe ES, Stein H (2017) Lymphoplasmacytic lymphoma. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO Classification of tumours of haematopoietic and lymphoid tissues, Revised 4th edn. International Agency for Research on Cancer, Lyon, pp 232–234
2. Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP (2005) Diagnosis and management of Waldenstrom macroglobulinemia. J Clin Oncol 23:1564–1577
3. Mazzucchelli M, Frustaci AM, Deodato M, Cairoli R, Tedeschi A (2018) Waldenstrom macroglobulinemia: an update. Mediterr J Hematol Infect Dis 10:e2018004
4. Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L, Pinkus GS, Rodig SJ, Sohani AR, Harris NL, Laramie JM, Skifter DA, Lincoln SE, Hunter ZR (2012) MYD88 L265P somatic mutation in Waldenstrom macroglobulinemia. N Engl J Med 367:826–833
5. Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Riboni R, Corso A, Orlandi E, Bonfichi M, Gotti M, Pascutto C, Mangiacavalli S, Croci G, Fiaccadori V, Morello L, Guerrera ML, Paulli M, Cazzola M (2013) Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom macroglobulinemia and related lymphoid neoplasms. Blood 121:2522–2528
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Levetiracetam/oxcarbazepine;Reactions Weekly;2021-04